Global

‡ In these countries please contact our distributor

IV3000

Moisture Responsive Catheter Dressing

IV3000

About IV3000

IV3000 is a dedicated range of IV dressings designed to meet the demands of modern IV site care. IV3000 offers several important features:

  • IV3000 film and unique grid pattern adhesive allowing optimum moisture vapour transfer to reduce moisture accumulation and bacterial growth4;
  • High MVTR (typically 14,000g/m2 minimum per 24hrs at 37°C);
  • Waterproof, allowing the patient to shower with the dressing in-situ5;
  • Features two improved7,8 securing strips and a documentation label.

Technology:

MVTR - Moisture Vapour Transmission Rate

The moisture-responsive technology1 of IV3000™ reacts in the presence of moisture or water by removing it from underneath the dressing, maintaining optimum conditions for the IV incision site.

At the same time, IV3000 acts as a bacterial and viral barrier2-3,6.  This is enhanced by the grid-pattern adhesive, which increases the moisture-responsive properties of the dressing.

Why is the moisture-responsive property so important in an IV dressing?

Unlike a wound which requires a moist environment to heal, an IV site needs to be moisture-free. This reduces the risk of bacterial proliferation, and in turn, helps the dressing stay in place.

References

1 L. Tompkins, "Data on File Report DS/07/224/R1a. IV3000 I-Hand Physical Properties.," 2008.

2 Smith & Nephew, "Bacterial barrier properties of IV3000 against Methicillin-Resistant Staphylococcus Aureus (MRSA) DOF 0505005" 2005.

3 Smith & Nephew, "Bacteria barrier testing of IV3000 Report WRP-TW042-281," 2003.

4 Richardson, MC An in vivo assessment of the microbial proliferation beneath transparent film dressing, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 29-33.

5 Besley, M OPSITE IV3000: potential for improved quality of life for haemodialysis patients with permanent central venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Synposium Series No. 179. Royal Society of Medicine Services Limited, 1991, pp. 57-59.

6 Smith & Nephew, Bacterial Viral Barrier Claim For IV3000 Transparent Dressing Family. Statement Reference 200409902-01, 2004.

7 Smith & Nephew, "Technical Study Report W11437/R21", 2013

8 Smith & Nephew, "Technical Study Report W11437/R22", 2013

The information on the date label in the banner image is for promotional purposes only.

What's New

IV Supplement

The IV supplement is supported by the British Journal of Nursing. It provides information about infection prevention in IV therapy, including case studies of nurses and patients using a range of our IV3000 dressings for various indications.

View the supplement in full.

IV3000 App

We have developed an interactive app to provide users with information about our product range.

The main purpose of the app is to keep you informed of IV3000’s product range via our sales team.

The app includes:

  • Product key benefits;
  • Product range; 
  • Application and removal tutorials;
  • Application posters. 

To view the app, please ask your Smith & Nephew sales representative to guide you through it.

Improved Securing strips and Date label1-2.

IV3000 new improved dressings include: two improved sterile securing strips1-2, ideal to be used on cannulas with wings or tube fixation; and an improved sterile documentation label1-2.

References

1 Smith & Nephew, "Technical Study Report W11437/R21," 2013.

2 Smith & Nephew, "Technical Study Report W11437/R22," 2013.

The information on the date label in the banner image is for promotional purposes only.

Product Benefits

THE FOUR PILLAR-benefits of using IV3000 as an IV site dressing

Risk of infection:

Reduces risk of infection through;

  • Reducing bacteria growth by preventing moisture accumulation thanks to IV3000 film that allows optimum moisture vapour transfer1-4;
  • Acting as a bacterial barrier5,6;
  • Acting as a viral barrier7;
  • Lowering incidence of device related septicemia3

 

Patient comfort

Provides greater patient comfort8 by:

  • Reducing pain on removal9;
  • Acting as a waterproof film, patient can shower with the dressing on10-12.

 

Skin integrity

Maintains skin integrity through other product features:

  • Low allergy adhesive3,4,9,13;
  • Prevents skin maceration1-2,11;
  • Non-irritating13;
  • Non-sensitizing13.

 

Clinical practice

Supports good clinical practice through:

  • Providing excellent catheter stability but easy to remove3,9,14-15;
  • The ability to be applied easily aseptically and removed easily9;
  • Minimizing unscheduled dressing changes16;
  • Permits the dressing to stay in place for up to 7 days10,17-18;
  • Permits continuous visualization of the catheter site

 

References

1 M. Richardson, An in vivo assessment of the microbial proliferation beneath transparent film dressing, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 29-33.

2 B. Joyeux, OPSITE™ IV3000 versus Tegaderm™ on peripheral venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Symposium Series No.179. Royal Society of Medicine Services Limited, 1991, pp. 53-55.

3 D. G. M. Maki, S. S. M. Stolz, S. B. Wheeler and L. A. D. S. Memel, "A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management," Critcial Care Medicine, vol. 22, no. 11, pp. 1729-1737, 1994.

4 D. G. Maki, "Preliminary Analysis of Data from the Triple-Lumen Central Venous Catheter Study," 1992.

5 Smith & Nephew, "Data On File Report 0505005. In-vitro," 2005.

6 Smith & Nephew, "Bacteria barrier testing of IV3000 Report WRP-TW042-281," 2003.

7 Smith & Nephew, Bacterial Viral Barrier Claim For IV3000 Transparent Dressing Family. Statement Reference 200409902-01, 2004.

8 S. Wheeler, S. Stolz and D. Maki, "A prospective, randomized, three-way clinical comparison of a novel, highly permeable, polyurethane dressing with 206 Swan-Ganz pulmonary artery catheters: OPSITE IV3000 vs Tegaderm vs gauze and tape," pp. 67-72, 1991.

9 J. Willie, B. Van Oud Alblas and E. Thewessen, "A comparison of two transparent film-type dressing in central vanous therapy," Journal of Hospital Infection, vol. 23, pp. 113-121, 1993.

10 M. Besley, OPSITE IV3000: potential for improved quality of life for haemodialysis patients with permanent central venous catheters, D. G. Maki, Ed., Improving catheter site care. Royal Society of Medicine Services International Congress and Synposium Series No. 179. Royal Society of Medicine Services Limited, 1991, pp. 57-59.

11 L. Tompkins, "Data on File Report DS/07/224/R1a. IV3000 I-Hand Physical Properties.," 2008.

12 "Preventing Hospital- Acquired Infection- Clinical Guidelines Public Health Laboratory Service," 1997.

13 G. Walton, "Safety Statement," 2011.

14 A. Wallace and B. Davy, "Report Ref. L/75A/23. To evaluate the skin response to, and tape performance of, single and repeat applications of high MVP dressings in human volunteers.," 1985.

15 D. Maki and M. Ringer, "Evalutation of Dressing Regimens for Prevention of Infection With Peripheral Intravenous Catheters," JAMA, vol. 258, no. 17, pp. 2395-2403, 6 Nov 1987.

16 M. Neufeld, A Randomized Control Trial of the effectiveness of Opsite Wound versus IV3000 in maintaining and Occlusive Central Line Dressing, McMaster University Canada, 1991.

17 D. R. R. Keenlyside, "Avoiding an unnecessary outcome. A comparative trial between IV3000 and a conventional film dressing to assess rates of catheter-related sepsis," Professional Nurse, pp. 288-291, February 1993.

18 C. Latta and C. Grant, "IV3000 dressing on Permcath exit sites," 1996.

All Trademarks acknowledged

The information on the date label in the banner image is for promotional purposes only.

Product Range

Selection of the correct dressing for insertion sites is advised as a best practice to prevent infections1.  IV3000 offers an extensive range of dressings designed to meet the most common IV therapy practices.

IV3000 offers an extensive range of dressings designed to meet the most common IV therapy practices including:

  • Peripheral;
  • Paediatric;
  • Central/PICC;
  • Epidural.

 

Ported Non-Ported
Ported Dressing Outline Illustration Non-Ported dressing outline illustration
Frame Delivery Reinforced Handle
Frame Delivery Outline Illustration Reinforced Handle Outline Illustration

 

View our product range in full.

References

1 H. Loveday and et al, "epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England," Journal of Hospital Infection, pp. S1-S70, 2014.

The information on the date label in the banner image is for promotional purposes only.

Resources

We offer various posters and videos to demonstrate how to apply our range of dressings.

Application Posters

Application Poster Snapshot

For specific dressing application posters, please click on the applicable products below.

Ported

7 x 9cm

(4006)

Non-Ported

6 x 7cm

(4007)

Non-Ported

10 x 12cm

(4008)

Ported

5 x 6cm

(66004011)

Ported

9 x 12cm

(66004009)

Frame Delivery

6 x 7cm

(59410082)

Application Videos

Ported application technique (S&N code 4006)

 

Ported removal technique (S&N code 4006)

 

Non-ported application technique (S&N code 4007)

 

The information on the date label in the banner image is for promotional purposes only.